ArticleFrontiers in surgery2026
Evaluating the impact of surgical resection on desmoid tumour growth: a retrospective analysis from the National Cancer Centre Singapore.
Article in Frontiers in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Desmoid tumours are locally aggressive, fibroblastic soft-tissue tumours which can affect adjacent structures. Management of desmoid tumours is multi-faceted and controversies surrounding surgical treatment stem from concerns about potential of surgery to precipitate tumour growth as pathogenesis of desmoid tumours is postulated to originate from trauma. Methods: Data from patients with desmoid tumours treated at the National Cancer Centre Singapore between 1999 and 2023 were collected retrospectively. We reviewed and compared radiological disease progression at one year for patients undergoing active surveillance and those who had surgical resection. Results: A total of 76 patients with desmoid tumours were seen in NCCS between September 1999 and October 2023; 19 patients were placed on active surveillance, and the remaining 57 patients underwent R0/ R1/ R2 wide excision of desmoid tumour. At one-year, progressive disease was observed in 5 out of 19 patients (26.3%) on active surveillance, and 13 out of 57 patients (22.8%) who underwent surgical resection. Progressive disease was observed in 5 out of 25 (20%) of patients following R0 resection, though no further progression occurred long-term, and all recurrences either stabilized or regressed. In the R1 group, 7 out of 28 (25%) patients showed progression at one year; management included repeat resection, cryoablation, or continued surveillance. Among R2 patients, 1 out of 4 patients had progressive disease with one patient maintaining complete radiological response at five years. Conclusion: Long-term outcomes following R0 resection were notably favourable, with no further progression and evidence of tumour stability or regression in all recurrent cases. Progressive disease rates at one year were comparable between surgical and surveillance groups, supporting a tailored, risk-adapted approach to management. Surgery does not appear to trigger tumour growth and achieves good disease control at one year, reinforcing its role as a viable option alongside active surveillance in selected patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.